Insights into Aspergillus fumigatus Colonization in Cystic Fibrosis and Cross-Transmission between Patients and Hospital Environments
- PMID: 39057346
- PMCID: PMC11277961
- DOI: 10.3390/jof10070461
Insights into Aspergillus fumigatus Colonization in Cystic Fibrosis and Cross-Transmission between Patients and Hospital Environments
Abstract
Background: Approximately 60% of individuals with cystic fibrosis (CF) are affected by Aspergillus fumigatus infection. This condition is correlated with a decline in lung function and is identified as an independent risk factor contributing to hospital admissions among CF patients. This study investigates the dynamic interplay of A. fumigatus within the context of CF patients, tracing its evolution over time, with a specific emphasis on colonization dynamics.
Methods: An analysis was conducted on 83 sequential A. fumigatus isolates derived from sputum samples of six patients receiving care at a renowned CF hospital in Brazil. Employing microsatellite genotyping techniques, alongside an investigation into cyp51A gene mutations, this research sheds light on the genetic variations, colonization, and resistance of A. fumigatus within the CF respiratory environment.
Results: Our research findings indicate that CF patients can harbor A. fumigatus strains from the same clonal complexes for prolonged periods. Additionally, we identified that clinical isolates have the potential to spread among patients in the same healthcare facility, evidencing hospital contamination. Two patients who underwent long-term Itraconazole treatment did not show phenotypic resistance. However, one of these patients exhibited mutations in the cyp51A gene, indicating the need to monitor resistance to azoles in these patients colonized for long periods by A. fumigatus. We also observed co-colonization or co-infection involving multiple genotypes in all patients over time.
Conclusion: This comprehensive examination offers valuable insights into the pathogenesis of A. fumigatus infections in CF patients, potentially shaping future therapeutic strategies and management approaches. This enhanced understanding contributes to our knowledge of A. fumigatus impact on disease progression in individuals with cystic fibrosis. Additionally, the study provides evidence of cross-contamination among patients undergoing treatment at the same hospital.
Keywords: Aspergillus fumigatus; cross-transmission; cystic fibrosis.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.J Clin Microbiol. 2011 Jun;49(6):2243-51. doi: 10.1128/JCM.00213-11. Epub 2011 Apr 20. J Clin Microbiol. 2011. PMID: 21508152 Free PMC article.
-
Determination of Azole Resistance and TR34/L98H Mutations in Isolates of Aspergillus Section Fumigati from Turkish Cystic Fibrosis Patients.Mycopathologia. 2018 Dec;183(6):913-920. doi: 10.1007/s11046-018-0297-y. Epub 2018 Sep 6. Mycopathologia. 2018. PMID: 30187246
-
Azole-Resistant Aspergillus fumigatus Among Danish Cystic Fibrosis Patients: Increasing Prevalence and Dominance of TR34/L98H.Front Microbiol. 2020 Aug 13;11:1850. doi: 10.3389/fmicb.2020.01850. eCollection 2020. Front Microbiol. 2020. PMID: 32903400 Free PMC article.
-
Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis.Curr Opin Pulm Med. 2012 Nov;18(6):632-8. doi: 10.1097/MCP.0b013e328358d50b. Curr Opin Pulm Med. 2012. PMID: 22965276 Review.
-
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy.Infect Drug Resist. 2016 Sep 20;9:229-238. doi: 10.2147/IDR.S63621. eCollection 2016. Infect Drug Resist. 2016. PMID: 27703383 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources